You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 55 results
 
  • Record 1 TO 55

  1. ALGORITHM FOR 3D IMAGING OF THE EYE'S POSTERIOR POLE

    SBC: LICKENBROCK TECHNOLOGIES, INC.            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services

  2. A METHOD TO DEVELOP A MODEL SYSTEM FOR NONRADIOACTIVE DNA HYBRIDIZATION/DETECTION FOR IDENTIFICATION OF BACTERIA WILL BE DEVELOPED.

    SBC: ENZO BIOCHEM, INC.            Topic: N/A

    A METHOD TO DEVELOP A MODEL SYSTEM FOR NONRADIOACTIVE DNA HYBRIDIZATION/DETECTION FOR IDENTIFICATION OF BACTERIA WILL BE DEVELOPED. DNA FOR AMPICILLIN RESISTANCE WILL BE LABELED WITH BIOTINYLATED DEOXYURIDINE TRIPHOSPHATE BY NICK TRANSLATION AND USED AS PROBE. COLONY HYBRIDIZATION PROCEDURES FOR THE DETECTION OF IN E. COLI WILL THEN BE DEVELOPED. DETECTION OF HYBRIDIZED BIOTINYLATED DNA WILL BE DO ...

    SBIR Phase I 1984 Department of Health and Human Services

  3. Analyzing Toxicity to Mammalian Cells by Flow Cyometry

    SBC: Litron Laboratories Ltd            Topic: N/A

    Our Phase I research program is based on years of research which strongly suggest that high speed f(FCM) is a technology that can significantly improve toxicity assays. Highly reliable clastogen andhave been developed in our laboratories where FCM has played a major role in processing and analyzinfollowing exposure. In both cases, a significant improvement over conventional assays has resulted.Pha ...

    SBIR Phase II 1996 Department of Health and Human Services

  4. AN ELECTRICAL APPROACH FOR IN VITRO TOXICOLOGY

    SBC: APPLIED BIOPHYSICS, INC.            Topic: N/A

    WE HAVE BEEN DEVELOPING A NEW MEANS TO ELECTRICALLY STUDY ANIMAL CELLS GROWN IN TISSUE CULTURE AND INTEND TO MAKE A COMMERCIAL DEVICE SUITABLE FOR USE IN THE MEDICAL/BIOLOGICAL RESEACH AND TESTING MARKET. THE INSTRUMENTAL METHOD, REFERRED TO AS ECIS (ELECTRIC CELL-SUBSTRATE IMPEDANCE SENSOR), IS A NON-INVASIVE TECHNIQUE THAT MEASURES SEVERAL PARAMETERS RELATED TO CELL BEHAVIOR, SOME OF WHICH HAVE ...

    SBIR Phase II 1996 Department of Health and Human Services

  5. A NETWORKED COMPUTER-MEDIATED SMOKING CESSATION PROGRAM

    SBC: Behavioral Health Systems Inc            Topic: N/A

    N/A

    SBIR Phase I 1984 Department of Health and Human Services

  6. ANTIVIRAL STRATEGY DIRECTED TOWARD HCV RNA TRANSLATION

    SBC: ONCOGENE SCIENCE, INC.            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services

  7. 4-AP THERAPY OF CHRONIC PAIN AND SPINAL INJURY

    SBC: Acorda Therapeutics, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services

  8. Caged Metal Cluster and Colloid Immunoprobes

    SBC: NANOPROBES INC            Topic: N/A

    New classes of immunolabels will be produced comprising large metal particles encapsulated within coordination shells of stabilizing ligands, the naturally occurring hollow protein apoferritin, or new synthetic inclusion molecules. The new probes will combine the high electron density, ease of visualization and range of sizes available with colloidal gold probes with the non-aggregation, high pene ...

    SBIR Phase II 1996 Department of Health and Human Services

  9. CD4 Based In Vivo Imaging Agents For HIV-1 Disease

    SBC: PROGENICS PHARMACEUTICALS, INC.            Topic: N/A

    We will develop two radioiodinated CD4-immunoglobulin chimetric proteins as novel in vivoimaging agents for HIV-1 disease. The two recombinant proteins are CD4-gamma2, a homodimercontaining two chains of a CD4-human IgG2 heavy chain fusion protein; and, CD4-IgG2, a heterotetram-er containing two chains of a CD4-human IgG2 heavy chain fusion protein and two chains of aCD4-human kappa light chain fu ...

    SBIR Phase II 1996 Department of Health and Human Services

  10. COMPUTER TELEPHONY COMPLIANCE SYSTEM FOR GLAUCOMA

    SBC: Xtend Communications            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
US Flag An Official Website of the United States Government